These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 11997157)
21. A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media. Heikkinen T; Saeed KA; McCormick DP; Baldwin C; Reisner BS; Chonmaitree T Acta Paediatr; 2000 Nov; 89(11):1316-21. PubMed ID: 11106042 [TBL] [Abstract][Full Text] [Related]
22. Pathogens in acute otitis media--impact of intermittent penicillin V prophylaxis on infant nasopharyngeal flora. Foglé-Hansson M; White P; Hermansson A Int J Pediatr Otorhinolaryngol; 2003 May; 67(5):511-6. PubMed ID: 12697353 [TBL] [Abstract][Full Text] [Related]
23. Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Brook I; Yocum P Pediatr Infect Dis J; 1995 Sep; 14(9):805-8. PubMed ID: 8559633 [No Abstract] [Full Text] [Related]
24. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. Richard MP; Aguado AG; Mattina R; Marre R J Antimicrob Chemother; 1998 Feb; 41(2):207-14. PubMed ID: 9533462 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US. Karlowsky JA; Draghi DC; Thornsberry C; Jones ME; Critchley IA; Sahm DF Int J Antimicrob Agents; 2002 Aug; 20(2):76-85. PubMed ID: 12297355 [TBL] [Abstract][Full Text] [Related]
26. The problem of resistant bacteria for the management of acute otitis media. Barnett ED; Klein JO Pediatr Clin North Am; 1995 Jun; 42(3):509-17. PubMed ID: 7761138 [TBL] [Abstract][Full Text] [Related]
27. [Nasopharyngeal and middle ear flora in children with acute otitis media]. Zielnik-Jurkiewicz B; Kolczyńska M Otolaryngol Pol; 2005; 59(4):537-42. PubMed ID: 16273858 [TBL] [Abstract][Full Text] [Related]
28. The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children. Suzuki K; Baba S; Inagaki M; Kobayashi T Auris Nasus Larynx; 1988; 15(2):105-11. PubMed ID: 3144965 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae. Doern GV; Vautour R Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521 [TBL] [Abstract][Full Text] [Related]
30. [Microbiology in acute otitis media]. Bingen E Rev Prat; 1998 Apr; 48(8):848-53. PubMed ID: 11767328 [TBL] [Abstract][Full Text] [Related]
31. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. McLinn S; Williams D Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239 [TBL] [Abstract][Full Text] [Related]
32. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Melo-Cristino J; Fernandes ML; Serrano N; Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801 [TBL] [Abstract][Full Text] [Related]
33. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681 [TBL] [Abstract][Full Text] [Related]
34. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. Blondeau JM; Suter M; Borsos S J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568 [TBL] [Abstract][Full Text] [Related]
35. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance. Doern GV Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856 [TBL] [Abstract][Full Text] [Related]
36. Activities of faropenem, an oral beta-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Critchley IA; Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Murfitt K; Sahm DF Antimicrob Agents Chemother; 2002 Feb; 46(2):550-5. PubMed ID: 11796376 [TBL] [Abstract][Full Text] [Related]
37. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era. Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414 [TBL] [Abstract][Full Text] [Related]
39. Isolation of nasopharyngeal beta-lactamase producing Haemophilus influenzae, in relation to antibiotic treatment of acute otitis media in infants. Freijd A; Rynnel-Dagöö B Acta Otolaryngol; 1983; 95(3-4):351-7. PubMed ID: 6404124 [TBL] [Abstract][Full Text] [Related]
40. Antibiotic resistance in pathogens causing acute otitis media in Finnish children. Sillanpää S; Sipilä M; Hyöty H; Rautiainen M; Laranne J Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():91-4. PubMed ID: 27240503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]